Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Immunopharmacology and Immunotoxicology|June 20, 2023
A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse eventXinqing Lin, Wenhui Guan, Bingliang Li, et al.
Frontiers in Immunology|June 21, 2021
Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 TherapyXinqing Lin, Guihuan Qiu, Fang Li, et al.
Thoracic Cancer|April 2, 2023
Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched studyJingyuan Xie, Mo Chen, Hedong Han, et al.
Frontiers in Oncology|July 30, 2021
Peripheral Blood Biomarkers for Early Diagnosis, Severity, and Prognosis of Checkpoint Inhibitor-Related Pneumonitis in Patients With Lung CancerXinqing Lin, Haiyi Deng, Yilin Yang, et al.
Journal of Cancer Research and Clinical Oncology|February 11, 2022
Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data studyXinqing Lin, Haiyi Deng, Suyang Li, et al.
Clinical Lung Cancer|January 23, 2025
Phase I Clinical Trial of Autologous Hematopoietic Stem Cell Transplantation-Supported Dose-Intensified Chemotherapy With Adebrelimab as First-Line Treatment for Extensive-Stage Small Cell Lung CancerMing Liu, Wenhui Guan, Xiaohong Xie, et al.
Heliyon|November 25, 2024
Biological and clinical characteristics of non-small cell lung cancer non-specific subtypeXiaohong Xie, Chen Zeng, Fei Wang, et al.
Translational Lung Cancer Research|December 15, 2022
Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case reportGuihuan Qiu, Suyang Li, Bingliang Li, et al.
Signal Transduction and Targeted Therapy|February 17, 2025
Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trialMing Liu, Guihuan Qiu, Wenhui Guan, et al.
Cancer Medicine|July 18, 2023
A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancerGuihuan Qiu, Fei Wang, Xiaohong Xie, et al.
Pageof 2